Symbicort® (budesonide/formoterol) Asthma

This website is intended for doctors, nurses, and pharmacists in the UK. Other UK residents please visit astrazeneca.co.uk.

References

  1. Symbicort Turbohaler 400/12, Inhalation powder. Summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/medicine/11882. last accessed February 2018.
  2. Symbicort Turbohaler 100/6, Inhalation powder. Summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/medicine/4820. last accessed February 2018.   
  3. Symbicort Turbohaler 200/6, Inhalation powder. Summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/medicine/4821. last accessed February 2018. 
  4. Asthma UK. Astham facts and statistics. https://www.asthma.org.uk/about/media/facts-and-statistics. last accessed February 2018.
  5. Selroos O. Ther Clin Risk Manag 2007;3:349–359.
  6. Tattersfield AE et al. Am J Respir Crit Care Med 1999;160:594–599.
  7. Kuna P et al. Int J Clin Pract 2007;61:725–736.
  8. Salamol Easi-Breathe. Summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/medicine/31697. last accessed February 2018.
  9. Royal College of Physicians. Why Asthma Still Kills? The National Review of Asthma Deaths (NRAD) [online] 2014.Available from: https://www.rcplondon.ac.uk/projects/outputs/why-asthma-still-kills .[Accessed: March 2018].
  10. Thomas M et al. NPJ Prim Care Respir Med 2015;25:14105.
  11. Home R. Chest 2006;130:65S–72S.
  12. BTS/SIGN. British guideline on the management of asthma. A National Clinical Guideline. SIGN 153. last accessed February 2018. Available from: https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2016/ last accessed February 2018.
  13. Seberová E and Andersson A. Respir Med 2000; 94: 607-611.

Asthma: GB-10607 

Date of preparation: February 2018